Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07807033) titled 'Observation of Immune Persistence in a Clinical Trial of an Adsorbed Tetanus Vaccine' on Sept. 2.

Study Type: Observational

Primary Sponsor: CanSino Biologics Inc.

Condition: Tetanus

Intervention: Other: Previously vaccinated with TTVA

Recruitment Status: Not recruiting

Date of First Enrollment: October 15, 2026

Target Sample Size: 240

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07807033

Disclaimer: Curated by HT Syndication....